Table 2.
Group | 90-Day mortality | Incident/progressive CKD |
---|---|---|
no-CKD | ||
no-AKI | 104/598 (17.4%) | 33/321 (10.3%) |
AKI 1 | 93/363 (25.6%) | 42/183 (22.9%) |
AKI ≥2 | 193/460 (42.0%) | 51/175 (29.1%) |
CKD | ||
no-AKI | 106/537 (19.7%) | 24/259 (9.3%) |
AKI 1 | 82/364 (22.5%) | 20/181 (11.0%) |
AKI ≥2 | 125/310 (40.3%) | 33/116 (28.4%) |
AKI, acute kidney injury; CKD, chronic kidney disease.
The 90-day mortality denotes all-cause death during index hospital admission or within 90 days of hospital discharge. Incident/progressive CKD (in patients without and with baseline CKD, respectively) was adjudicated in survivors during median follow-up of 15.3 months.